RHB-104 in CD

Print

Details of Research

Contact: Shelley Mikolainis, Research Coordinator
416-586-4800 ext 4989
smikolainis@mtsinai.on.ca

Primary Investigator: Dr. Hillary Steinhart

Enrolment: Ongoing

Expectation: 9/14 visits require the patient to stay for 3 hours for PK testing

Eligibility


Exclusions
: active or healed fistula within last 2 months, on meds that prolong QT interval or are a CYP3A4 substrate, oral/IV antibiotcs or probiotics within 4 weeks to BL, history or current uveitis